Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00771537 · ClinicalTrials.gov registry record · Phase 3
HIV Testing & Womens Attitudes on HIV Vaccine Trials
A Phase 3 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,031
- Enrollment target
NCT00771537: Completed Phase 3 study, sponsored by Indiana University.
NCT00771537 is a Phase 3 study that has completed, run by Indiana University. The registered enrollment target is 2,031 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (163% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00771537, a Phase 3 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,031 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of different persuasive informational messages on rates of rapid HIV testing and willingness to participate in a HIV vaccine clinical trial. Adult African-American, non-Latina White, and Latina women will be recruited. Women will initially be randomized to 4 groups: 1. no message control; 2. 1-sided message that mentions benefits of HIV testing; 3. 2-sided message that acknowledges minor opposition to testing, then refutes the opposition; and 4. 2-sided message that acknowledge stronger opposition to testing, then refutes the opposition. Women will be offered HIV testing, then re-randomized to a similar set of 4 messages related to HIV vaccine trials. There will therefore be 16 groups in total (4 X 4).
Primary Outcome
Acceptance of rapid HIV testing. Acceptance was assessed by actual administration of rapid oral HIV test by research staff.
Interventions
- BEHAVIORAL Message Sidedness
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,031 participants |
| Start Date | 2006-11 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
What the finished NCT00771537 record still lists
NCT00771537 is an interventional study that assigns participants to a tested intervention. Its 2,031 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (163% higher).
The record links to 0 conditions, and to 1 intervention - of which Message Sidedness is the first listed.
NCT00771537 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00771537 about?
NCT00771537 is a clinical study titled "HIV Testing & Womens Attitudes on HIV Vaccine Trials". The purpose of this study is to test the effects of different persuasive informational messages on rates of rapid HIV testing and willingness to participate in a HIV vaccine clinical trial. Adult African-American, non-Latina White, and Latina women will be recruited. Women will initially be randomiz...
What is the current status of trial NCT00771537?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,031 participants. The study started on 2006-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00771537?
The interventions under investigation include: Message Sidedness (BEHAVIORAL).
Who is sponsoring clinical trial NCT00771537?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00771537's enrollment target sits among peer trials
2,031 100th of 2000 higher than 1,901 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia